Litcius/Paper detail

Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery

Andrew L. Lewis, Nicholas McEntee, Justin Holland, Asma Patel

2021Drug Delivery and Translational Research77 citationsDOI

Topics & Concepts

MedicineClinical trialBiopharmaceuticalMilestonePharmacologyIntensive care medicineInternal medicineBiotechnologyArchaeologyBiologyHistoryAdvanced Drug Delivery SystemsDrug Solubulity and Delivery SystemsDiabetes Treatment and Management
Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery | Litcius